Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
changes decrease » largest decrease (Expand Search), change increases (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 761 - 780 results of 8,320 for search '(( significant progress decrease ) OR ( significant ((changes decrease) OR (larger decrease)) ))', query time: 0.47s Refine Results
  1. 761
    General procedure for the synthesis of B.

    General procedure for the synthesis of B. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  2. 762
    The trends of gene expression in the metabolism of triglycerides in liver tissue.

    The trends of gene expression in the metabolism of triglycerides in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  3. 763
    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.

    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  4. 764
    The trends of cholesterol metabolism-related gene expression in liver tissue.

    The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  5. 765
    <sup>1</sup>H NMR spectra for kylo-0603.

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  6. 766
    Kylo-0603’s EC50 & tissue levels.

    Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  7. 767
    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.

    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  8. 768
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  9. 769
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  10. 770
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  11. 771
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  12. 772
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  13. 773
    <sup>13</sup>C NMR spectra for Kylo-0603.

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  14. 774
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  15. 775
    DIO Mice Liver Staining.

    DIO Mice Liver Staining. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  16. 776
    Trends of peroxisome-related gene expression in liver tissue.

    Trends of peroxisome-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  17. 777
    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).

    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  18. 778
    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combined with digital image analysis technique.

    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  19. 779
    The structures of T3 and Kylo-0603.

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:
  20. 780
    Synthesis process of Kylo-0603.

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
    Save to List
    Saved in:

Search Tools: